tiprankstipranks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market

Vir Biotechnology (VIR) Stock News & Sentiment

1,136 Followers
Vir Biotechnology completes Phase 2 SOLSTICE clinical trial ahead of schedule
PremiumThe Fly
Vir Biotechnology completes Phase 2 SOLSTICE clinical trial ahead of schedule
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Vir Biotechnology Ends Influenza Deal with GlaxoSmithKline
PremiumCompany Announcements
Vir Biotechnology Ends Influenza Deal with GlaxoSmithKline
2M ago
Vir Biotechnology reports Q4 EPS (86c), consensus ($1.01)
PremiumThe Fly
Vir Biotechnology reports Q4 EPS (86c), consensus ($1.01)
2M ago
Vir Biotechnology Announces Executive Leadership Transition
PremiumCompany Announcements
Vir Biotechnology Announces Executive Leadership Transition
2M ago
Vir Biotechnology Chief Medical Officer to step down
PremiumThe Fly
Vir Biotechnology Chief Medical Officer to step down
2M ago
More VIR News >

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VIR’s Media Buzz Sentiment?
Currently, no data Available
What is VIR’s weekly average amount of articles?
Currently, no data Available
What is VIR’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
STROSutro Biopharma
MASIMasimo
THRDThird Harmonic Bio, Inc.
STOKStoke Therapeutics
BCABBioAtla
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis